Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
99.50
+0.11 (0.11%)
At close: Oct 6, 2025, 4:00 PM EDT
97.00
-2.50 (-2.51%)
After-hours: Oct 6, 2025, 5:25 PM EDT

Monopar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
7171345314070
Upgrade
Market Cap Growth
4425.02%2552.79%-83.48%-24.23%-42.34%-59.48%
Upgrade
Enterprise Value
664128-3161852
Upgrade
Last Close Price
99.5022.001.7011.8516.0530.60
Upgrade
PB Ratio
11.682.440.913.042.134.47
Upgrade
P/TBV Ratio
13.732.440.913.042.134.47
Upgrade
Debt / Equity Ratio
0.00--0.00--
Upgrade
Quick Ratio
33.6311.464.144.1912.8514.22
Upgrade
Current Ratio
33.9411.484.174.2112.9814.28
Upgrade
Return on Equity (ROE)
-59.38%-51.42%-107.19%-72.45%-52.57%-44.52%
Upgrade
Return on Assets (ROA)
-39.12%-29.87%-53.66%-39.03%-30.51%-26.92%
Upgrade
Return on Capital (ROIC)
-40.89%-33.32%-70.38%-45.36%-32.94%-28.73%
Upgrade
Earnings Yield
-2.41%-11.62%-166.13%-34.34%-22.52%-9.00%
Upgrade
Buyback Yield / Dilution
-80.26%-37.09%-8.70%-1.97%-13.82%-17.56%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q